Company Directory / Biopharma
PrivateFor profitBiopharmaTokyo, Japan
Renalys Pharma
Renalys Pharma is a private, late-stage clinical biopharmaceutical business in Japan focused on the discovery of novel medications.
- Founded
- 2023 3 years ago
- Staff
- - band, as listed
- Followers
- - on LinkedIn
- Funding
- $6.0B as listed, currency not stated
Set against six million companies
Size
Size not listed
Age
3 years old.
Reach
No web traffic ranking listed.
Funding, as listed
$6.0B currency not stated
- Rounds1
- LatestSeries a, Jul 2024
- Investors6, 2 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Renalys Pharma, field by field. Contact details are held but never shown.
The company
- Name
- Renalys Pharma
- Type
- For profit
- Status
- Private
- Founded
- 2023
- Founders
- BT Slingsby, Takeshi Takahashi
- Industry
- Biopharma
Where
- City
- Tokyo
- Country
- Japan
- Markets
- Asia-Pacific (APAC)
Funding, as listed
- Total
- 6,000,000,000 (currency not stated)
- Rounds
- 1
- Latest round
- Series a
- Latest round date
- Jul 2024
- Investors
- 6
- Lead investors
- 2
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Companies like it
Biopharma in Japan.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 32,492 companies in Japan and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.